Actively Recruiting
Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
Led by University Children's Hospital, Zurich · Updated on 2026-03-04
100
Participants Needed
1
Research Sites
969 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was feared. Recent data proof that the risk for malignancy was overestimated. Nowadays still a lot of patients express their wish for surgical removal out of aesthetic reasons and psychological impacts. Many patients and families experience stigmatization because of the nevus. To proof a medical indication for surgical removal the investigators want to evaluate the quality of life and stigmatization before and after nevus surgery.
CONDITIONS
Official Title
Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a congenital melanocytic nevus of at least 2 cm² that will be surgically removed
- Age between 9 months and 16 years
You will not qualify if you...
- Mental retardation of the child
- Insufficient knowledge of the German language of both parents
- Severe comorbidities
- Previous therapies done for the CMN such as dermabrasion, surgery, or laser
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Children's Hospital Zurich, Division of Pediatric Plastic and reconstructive Surgery
Zurich, Switzerland, 8008
Actively Recruiting
Research Team
K
Kathrin Neuhaus, MD
CONTACT
M
Markus Landolt, Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here